Table 7.

Percentage of excess BMI lost at 1 and 5 year(s) following RYGB and VSG and percentage of patients achieving remission of comorbidites at 5 year follow-up (n=217)¹⁵.

	% Excess BMI lost after 1 year	% Excess BMI lost after 5 years	% of patients acheiving remission of comorbidity at 5 years
			T2DM	Dyslipidaemia	Hypertension
RYGB	76.70	68.30	67.90	62.30	70.30
VSG	72.40	61.10	61.50	42.60	62.50

There was no significant difference between RYGB and VSG for excess BMI lost at 1 or 5 years or for comorbidity resolution at 5 years.¹⁵

RYGB, Roux-en-Y gastric bypass; T2DM, type 2 diabetes mellitus; VSG, vertical sleeve gastrectomy.